Clinical Trials Imaging Market worth 981.53 Million USD by 2020

The report "Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020", report provides a detailed overview of the major drivers, restraints, opportunities, challenges and trends impacting the global clinical trials imaging market along with the estimates and forecasts of the revenue and market share analysis.

The global clinical trials imaging market is expected to reach USD 981.53 Million by 2020 from USD 724.87 Million in 2015, growing at a CAGR of 6.25%. Growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs are the primary growth drivers for this market during the forecast period (2015–2020). However, high implementation cost of imaging systems may hinder the growth of this market.

The global clinical trials imaging market is segmented on the basis of products, modality and end-users. On the basis of products, the market is segmented into services & software. Of these, the services product segment accounted for the largest share of the global clinical trials imaging market in 2015.

By modality, the market is divided into CT, MRI, ultrasound, PET, X-rays, ECHO and other modalities. Of these, the CT accounted for the largest growing segment in the global clinical trials imaging market by 2020. On the other hand, PET accounted for the fastest growing segment in the global clinical trials imaging market. On the basis of end-users, the clinical trials imaging market is categorized into pharmaceutical companies, biotechnology companies, medical device companies/manufacturers, CROs, academic & government research institutes & other end-users.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW).

The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

The global clinical trials imaging market is expected to reach USD 981.53 Million by 2020 from USD 724.87 Million in 2015, growing at a CAGR of 6.25%.

Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India

This release was published on openPR.